Bridging the Gap between Evidence and Practice: Nationwide Retrospective Analysis of Lipid-Modifying Therapy Prescription Patterns in 5 Million Patients with Type 2 Diabetes Mellitus

Our findings revealed a significant under-prescription of lipid-modifying therapy in T2DM patients. The universal nature of under-prescription suggests barriers to guideline implementation. These results underscore the urgent need for systematic interventions, including automated identification systems, standardized protocols, and optimized provider education to improve cardiovascular risk management in patients with T2DM.

Authors

Institutions

Publication Details

Journal
ASIDE Internal Medicine
Published
2025-08-25
DOI
https://doi.org/10.71079/aside.im.08252522
Citations
1
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
2.01

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bridging the Gap between Evidence and Practice: Nationwide Retrospective Analysis of Lipid-Modifying Therapy Prescription Patterns in 5 Million Patients with Type 2 Diabetes Mellitus

Omar Nassar, Nourhan Ahmed, Salem Badr, Anoop Misra et al.
1 citations
ASIDE Internal Medicine
Lipoproteins and Cardiovascular Health
2.01
article

Bridging the Gap between Evidence and Practice: Nationwide Retrospective Analysis of Lipid-Modifying Therapy Prescription Patterns in 5 Million Patients with Type 2 Diabetes Mellitus

Omar Nassar, Nourhan Ahmed, Salem Badr, Anoop Misra, Sherif Eltawansy, Muhammed Amir Essibayi, Mahmoud Nassar, Diaa Hakim, Ahmed Y. Azzam, Ahmed Hassan, Aisha Siraj, Mohamed Reyad, Menna A. Keshk
article en
1 citations

Abstract

Our findings revealed a significant under-prescription of lipid-modifying therapy in T2DM patients. The universal nature of under-prescription suggests barriers to guideline implementation. These results underscore the urgent need for systematic interventions, including automated identification systems, standardized protocols, and optimized provider education to improve cardiovascular risk management in patients with T2DM.

ASIDE Internal MedicineVol. 2(2)
University of Vermont (US), Brigham and Women's Hospital (US), Albert Einstein College of Medicine (US), Suez University (EG), Montefiore Medical Center (US), Harvard University (US), Seoul National University (KR), Cairo University (EG), Champlain Valley Union High School (US), Banner - University Medical Center Phoenix (US), Aurora St. Luke's Medical Center (US), Ministry Of Health (FJ), National Diabetes Obesity and Cholesterol Foundation (IN), MetroHealth Medical Center (US), Ministry of Health and Population (EG), Jersey Shore University Medical Center (US)
Georgia Clinical and Translational Science Alliance, National Institutes of Health, National Center for Advancing Translational Sciences
Openalex Percentile: Top 12%
Lipoproteins and Cardiovascular Health
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.